The chemical class known as ZNF21 inhibitors encompasses a diverse range of compounds that can affect the activity of theZNF21. These inhibitors operate through various mechanisms, targeting different stages of the protein's life cycle or its interaction with other cellular components. The focus is primarily on altering the transcriptional regulatory functions of ZNF21, which is a member of the larger family of zinc finger proteins that typically bind to DNA and influence gene expression. The compounds in this class can interfere with the crucial processes that are necessary for ZNF21 to exert its normal biological functions, such as DNA binding, protein-protein interactions, post-translational modifications, and the assembly of transcriptional machinery.
The action of ZNF21 inhibitors can start at the genomic level, where certain compounds integrate into the genetic material and disrupt the normal epigenetic landscape. By affecting DNA methylation and histone modification patterns, these chemicals can change the chromatin structure, influencing the accessibility of ZNF21 to its target DNA sequences. Other inhibitors can act post-translationally by modifying the structure of ZNF21 or its associated cofactors, which can alter the protein's stability, localization, or capacity to engage in essential interactions within the cell. Additionally, the modulation of upstream signaling pathways that govern the activity of transcription factors can also be a strategy employed by these inhibitors. By intervening in kinase signaling cascades or other regulatory networks, these compounds can indirectly influence the functional state of ZNF21, leading to altered gene expression profiles. It is important to recognize that these inhibitors work within the complex web of cellular processes, and their effects on ZNF21 are intertwined with broader impacts on cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that incorporates into DNA and RNA, leading to hypomethylation of DNA. It could possibly inhibit ZNF21 by disrupting normal methylation-dependent regulation of gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that could possibly inhibit ZNF21 by altering chromatin structure and gene expression, impacting the protein's ability to regulate its target genes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
An aldehyde dehydrogenase inhibitor that could possibly inhibit ZNF21 by altering the zinc finger domains in proteins and affecting their DNA-binding capacity. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A chemotherapeutic agent that forms DNA adducts and could possibly inhibit ZNF21 by disrupting DNA replication and transcription, affecting the binding and function of DNA-binding proteins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK in the MAPK/ERK pathway that could possibly inhibit ZNF21 by regulating the activity of various transcription factors. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK kinase that could possibly inhibit ZNF21 by altering signaling pathways that regulate transcription factors. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could possibly inhibit ZNF21 by affecting various signaling pathways, including those regulating transcription factors and gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that could possibly inhibit ZNF21 by affecting cell growth and protein synthesis, impacting the synthesis and function of transcription factors. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could possibly inhibit ZNF21 by leading to increased levels of proteins within the cell, affecting the stability and function of transcription factors. | ||||||